• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

CrowdStrike Is Still Likely to Weaken Further

Here's why I remain cautious on the cybersecurity stock.
By BRUCE KAMICH
Mar 17, 2021 | 09:39 AM EDT
Stocks quotes in this article: CRWD, MSFT

For his final "Executive Decision" segment of Mad Money Tuesday night, Jim Cramer checked in with George Kurtz, CEO of CrowdStrike (CRWD) , the cybersecurity company that protects over 50% of the Fortune 100 companies, but also small and mid-size businesses too.

When asked about the types of threats companies are facing, Kurtz explained that ransomware attacks are more prominent than ever.

Kurtz then commented on the recent SolarWinds attacks that threatened national security. He said that the attacks used flaws in antiquated Microsoft (MSFT) technologies that "have to be fixed" or we risk similar attacks in the future.

When we looked at CRWD on March 11 we wrote that "...We have charts and indicators that suggest further declines in the weeks ahead but we have a secular bull market where so many traders and investors are convinced you need to 'buy the dip'... My strategy suggestion is that we should give things a little more time."

In the updated daily bar chart of CRWD, below, we can see that the shares have bounced in recent days but that has done little to improve the picture. Prices are still below the declining 50-day moving average line. The 200-day moving average line is still rising and below the price action but it has gotten closer.

The On-Balance-Volume (OBV) line is still in a downtrend and tells me that sellers of CRWD remain more aggressive. The Moving Average Convergence Divergence (MACD) oscillator is still below the zero line in sell territory but it has narrowed and could generate a cover shorts buy signal in the near future if prices continue to firm.

In the weekly Japanese candlestick chart of CRWD, below, we can see that the two most recent candles show upper shadows, which tell us that traders have rejected the highs. The 40-week moving average is still bullish but is starting to crest.

The weekly OBV line has been moving sideways to lower from December. The MACD oscillator crossed to the downside in February for a take profits sell signal.

In this daily Point and Figure chart of CRWD, below, we still see a bearish price target of $110. Support on the weekly candle chart is likely in the $150-$120 area.

Bottom-line strategy: Yes the need for cybersecurity is probably greater than ever, but that need may already be discounted in the price action. I remain cautious on CRWD.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Cybersecurity | Software & Services | Technology | Mad Money | Executive Interview

More from Stocks

You Can Invest in Micron, But Here's Why You May Want to Wait

Stephen Guilfoyle
Jul 1, 2022 10:15 AM EDT

MU reported earnings Thursday night and the guidance was shocking.

The Charts Point to More Selling Ahead for 4 Former Tech Leaders

Ed Ponsi
Jul 1, 2022 10:00 AM EDT

Keep in mind that no matter how much a stock has fallen, it can always go lower, and it appears these four stocks could prove that point.

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

Bruce Kamich
Jul 1, 2022 9:41 AM EDT

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

A Few Thoughts on How to Approach a Tougher Bear Market Than Most

Bob Byrne
Jul 1, 2022 8:30 AM EDT

A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login